润科生物品牌怎么样 申请店铺

我要投票 润科生物在DHA藻油行业中的票数:885 更新时间:2026-01-29
润科生物是哪个国家的品牌?「润科生物」是 广东润科生物工程股份有限公司 旗下著名品牌。该品牌发源于广东省汕头市,由创始人陈 *在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力润科生物品牌出海!将品牌入驻外推网,定制润科生物品牌推广信息,可以显著提高润科生物产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

润科生物怎么样

广东润科生物工程股份有限公司于2000年5月创立于广东汕头,是一家应用现代生物工程技术进行研发、生产源于海洋微藻的人类健康产品的企业。公司成立以来一直专注于研发、生产和销售食品强化剂,利用生物工程技术培养富含DHA(二十二碳六烯酸)海洋微藻、培育高含量ARA(花生四烯酸)细胞,并分别提取DHA营养强化剂和ARA营养强化剂,主要产品为DHA藻油、DHA粉剂、ARA油脂、ARA粉剂、DHA+ARA混合粉。DHA属于N-3系多不饱和脂肪酸,能促进脑细胞的生长和神经网络的形成,有利于智力与神经的改善;ARA属于N-6系多不饱和脂肪酸,有利于体格的发育。

广东润科生物工程股份有限公司成立之后,研发成功突破了微藻DHA关键技术,是世界上较早拥有微藻DHA生产关键技术的生产厂家之一。公司同时也是ARA专业生产商。公司以市场为导向,依靠技术创新,始终坚持以高稳定性、高纯净度为质量目标,主要研究方向是DHA和ARA产品的开发及其在乳制品行业、粮油行业、食品行业、保健品行业中的添加及拓展应用。

在技术创新方面,公司迄今获得国家发明专利18项,实用新型专利28项,外观设计专利2项,已受理申请发明专利17项,已受理申请实用新型专利1项;科技成果转化方面,共承担科研项目6项,省市科技厅、经贸厅、发改委、知识产权局项目18项。公司参与已发布实施的国家标准《食品添加剂 二十二碳六烯酸油脂(发酵法)》和《食品添加剂 花生四烯酸油脂(发酵法)》的起草制定,参与已发布实施的行业标准《DHA藻油》的起草制定。

在研发方面,公司先后承担了国家创新基金项目“利用生物反应器高密度异养培养海洋微原生生物生产DHA微藻”、国家火炬计划项目“40吨级发酵罐异养培养富含DHA海洋微藻”、国家创新基金项目“微藻DHA在食品领域中的推广应用”、福建省发改委618优秀项目“利用海洋微藻异养培养技术生产长链多不饱和脂肪酸DHA微藻油产业化示范”;公司目前拥有“汕头市海洋微藻及真菌微生物应用研究工程技术研究开发中心”、“漳州市企业技术创新中心”、“广东省省级企业技术中心”、“广东省海洋微藻生物工程技术研究开发中心”、“福建省海洋微藻培育及功能成分开发企业工程技术研究中心”等多个省市级的技术研究开发中心。研发团队以博士、硕士研究生和高级工程师为主,公司研发总监姜悦为国家“千人计划”创新人才,系微生物和食品生物技术专家,在微生物工程、微藻生物资源技术、食品生物及食用天然产物功能因子结构和表征等方面研究成果显著。

在质量保证方面,公司秉持“质量就是企业生命之本”的原则,采取全员、全环节的质量控制手段。公司分别通过ISO9001质量管理体系认证、HACCP-EC-01食品安全管理体系认证、ISO22000食品安全管理体系认证、ISO14001环境管理体系认证、HACCP危害分析与关键控制点体系认证。

公司产品以优质的质量保证分别通过STAR-K颁发的Kosher犹太认证、印度尼西亚乌拉玛委员会(简称MUI)的HALAL清真认证、欧盟新资源食品(简称NOVEL FOOD)爱尔兰食品安全局的普通食品领域的实质等同(SE)认证、欧洲饲料添加剂和预混合饲料行业协会(简称FAMI)的QS管理体系认证、美国国家卫生基金会(简称NSF)的GMP认证、美国食药局(简称FDA)的GRAS普通食品领域认证、欧盟新资源食品(简称NOVEL FOOD)爱尔兰食品安全局的婴配领域的实质等同(SE)认证、美国食药局(简称FDA)的GRAS婴配领域的认证。公司目前与国内多家乳制品企业,如蒙牛、伊利、贝因美、君乐宝、完达山、飞鹤、光明、雅士利、羊羊100、百跃羊乳、明一等建立了业务合作关系,同时拓展了海外市场。


Guangdong runke Bioengineering Co., Ltd. was founded in Shantou, Guangdong Province in May 2000. It is an enterprise that applies modern bioengineering technology to develop and produce human health products derived from marine microalgae. Since its establishment, the company has been focusing on the research and development, production and sales of food fortifiers. It uses bioengineering technology to cultivate marine microalgae rich in DHA (docosahexaenoic acid) and high-content ara (arachidonic acid) cells, and extracts DHA nutritional fortifier and Ara nutritional fortifier respectively. Its main products are DHA algal oil, DHA powder, Ara oil, Ara powder and DHA + ara mixed powder. DHA belongs to n-3 polyunsaturated fatty acids, which can promote the growth of brain cells and the formation of neural networks, and is conducive to the improvement of intelligence and nerves; ara belongs to n-6 polyunsaturated fatty acids, which is conducive to physical development. After the establishment of Guangdong runke Bioengineering Co., Ltd., it has successfully broken through the key technology of microalgae DHA, and is one of the earliest manufacturers in the world with key technology of microalgae DHA production. The company is also a professional manufacturer of Ara. The company is market-oriented, relying on technological innovation, and always adheres to the quality goal of high stability and high purity. Its main research direction is the development of DHA and Ara products and their addition and expansion in the dairy industry, grain and oil industry, food industry and health care industry. In terms of technological innovation, the company has so far obtained 18 national invention patents, 28 utility model patents, 2 design patents, 17 invention patents and 1 utility model patent; in terms of transformation of scientific and technological achievements, the company has undertaken 6 scientific research projects, 18 projects of provincial and municipal science and technology departments, economic and trade departments, development and Reform Commission and intellectual property office. The company participated in the drafting and formulation of the national standards "food additive docosahexaenoic acid oil (fermentation law)" and "food additive arachidonic acid oil (fermentation law)", and participated in the drafting and formulation of the industry standard "DHA algae oil" which has been issued and implemented. In terms of research and development, the company has successively undertaken the national innovation fund project of "using bioreactor to cultivate marine micro protozoa with high density heterotrophic cultivation to produce DHA microalgae", the national Torch Program project of "heterotrophic cultivation of marine microalgae rich in DHA in 40 ton fermentor", the national innovation fund project of "promotion and application of microalgae DHA in the food field", and the outstanding project of Fujian Provincial Development and Reform Commission 618 At present, the company has "Shantou engineering technology research and development center of marine microalgae and fungi application research", "Zhangzhou enterprise technology innovation center", "Guangdong provincial enterprise technology center", "Guangdong marine microalgae bioengineering technology research and development center", and "Guangdong marine microalgae bioengineering technology research and development center" Many provincial and municipal technology research and development centers, such as Xin, Fujian engineering technology research center of marine microalgae cultivation and functional component development enterprises. The R & D team is mainly composed of Ph.D., master's degree and senior engineer. Jiang Yue, director of R & D of the company, is a national "thousand talents plan" innovation talent. He is an expert in Microbiology and food biotechnology. He has made remarkable research achievements in microbial engineering, microalgae biological resource technology, food biology and functional factor structure and characterization of edible natural products. In terms of quality assurance, the company adheres to the principle of "quality is the foundation of enterprise life", and adopts all staff and all links of quality control means. The company has passed ISO9001 quality management system certification, haccp-ec-01 food safety management system certification, ISO22000 food safety management system certification, ISO14001 environmental management system certification, HACCP hazard analysis and key control point system certification. The company's products have passed kosher Jewish certification issued by star-k, halal halal certification issued by Ulama Committee of Indonesia (MUI), substance of general food field of Irish food safety agency of new resources food of European Union (novelfood), QS management of European feed additive and premixed feed industry association (fami) Physical system certification, GMP certification of NSF, gras general food certification of FDA, Se certification of novelfood, and gras infant formula certification of FDA. At present, the company has established business cooperation with many domestic dairy products enterprises, such as Mengniu, Yili, beiinmei, JUNLEBAO, Wandashan, Feihe, Guangming, Yashili, Yangyang 100, Baiyue Yangru, Mingyi, etc., and expanded overseas market.

本文链接: https://brand.waitui.com/3a5a86006.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

股指剪刀差持续拉大,私募加紧演练“攻守平衡术”

2026开年以来,A股市场交投热度持续高企,但主要股指却表现分化。截至1月28日,中证500指数开年以来的涨幅超过15%,中证1000、国证2000指数亦涨逾10%。与之形成鲜明对比的是,上证50指数仅微涨0.97%,沪深300指数涨幅为1.90%。不同股指之间的“剪刀差”持续拉大。在市场结构急剧变化的背景下,多家一线私募机构对投资逻辑、潜在风险及策略应对进行了深入分析。多数机构认为,这一分化主要由增量资金的结构偏好与宏观流动性驱动,且已累积了明显的结构性风险。整体来看,市场风格的再平衡随时可能出现,投资者在“进攻”的同时,需要时刻记牢“防守”。(中证报)

47分钟前

现货黄金回落至5500美元以下,短线回落超100美元

36氪获悉,现货黄金回落至5500美元以下,短线回落超100美元,此前一度逼近5600美元/盎司。

47分钟前

公募基金调研活动持续升温,重点“掘金”科技成长方向

2026年1月以来,公募基金调研活动持续升温,科技成长板块成为核心布局方向,AI应用、商业航天、创新药及半导体等领域的上市公司获得重点关注。其中,大金重工、翔宇医疗、海天瑞声、爱朋医疗、熵基科技、美好医疗、博拓生物、天承科技、三七互娱、航天宏图等多家企业均获超百家机构调研。多位基金经理密集调研细分赛道龙头企业,聚焦技术壁垒高、场景落地明确的优质标的,清晰反映出机构对科技领域“技术突破+业绩兑现”的双重重视。(证券时报)

47分钟前

马斯克:特斯拉将停产Model S和Model X,全力投入Optimus研发

当地时间1月28日,特斯拉首席执行官马斯克在财报会议上表示,公司将在下个季度停产Model S和Model X车型。“现在是时候让Model S和Model X项目光荣退役了,因为我们正真正迈向以自动驾驶为核心的未来,”马斯克表示。马斯克还透露,特斯拉正将加州弗里蒙特工厂的Model S和Model X生产线替换为Optimus生产线,其长期目标是实现年产百万台机器人的产能。(界面)

48分钟前

中信建投:预计由AI等带来的光纤需求将持续较快增长

36氪获悉,中信建投证券研报认为,预计由AI等带来的光纤需求将持续较快增长:一是考虑到全球光模块需求量在2026年仍将大幅增长,则对应光纤需求也将随之增长(主要为Scale out需求);二是预计2027年左右Scale up的光纤需求可能起量,康宁展望Scale up的需求量将是现有企业网业务的2-3倍;三是Sacle Across也将带来大量的需求。此轮需求提升叠加价格上涨的预期,行业内的龙头厂商将率先受益,可能盈利与估值双提升。

48分钟前

本页详细列出关于润科生物的品牌信息,含品牌所属公司介绍,润科生物所处行业的品牌地位及优势。
咨询